Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pHAGE N-mRuby3 (from SARS-CoV-2) IRES puro Citations (2)

Originally described in: Pharmacological perturbation of intracellular dynamics as a SARS-CoV-2 antiviral strategy
Bakhache W, Partiot E, Lucansky V, Bare Y, BonaventurB V, Goujon C, Bories C, Deffieu M.S, Gaudin R bioRxiv 2021 Journal

Articles Citing pHAGE N-mRuby3 (from SARS-CoV-2) IRES puro

Articles
Delivery of Antibody-Like Molecules, Monobodies, Capable of Binding with SARS-CoV-2 Virus Nucleocapsid Protein, into Target Cells. Khramtsov YV, Ulasov AV, Lupanova TN, Georgiev GP, Sobolev AS. Dokl Biochem Biophys. 2022 Oct;506(1):220-222. doi: 10.1134/S1607672922050088. Epub 2022 Oct 27. PubMed
Intracellular Degradation of SARS-CoV-2 N-Protein Caused by Modular Nanotransporters Containing Anti-N-Protein Monobody and a Sequence That Recruits the Keap1 E3 Ligase. Khramtsov YV, Ulasov AV, Lupanova TN, Slastnikova TA, Rosenkranz AA, Bunin ES, Georgiev GP, Sobolev AS. Pharmaceutics. 2023 Dec 19;16(1):4. doi: 10.3390/pharmaceutics16010004. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.